ERGO (Entia Biosciences) Interest Expense: $-0.08 Mil (TTM As of Dec. 2016)


What is Entia Biosciences Interest Expense?

Entia Biosciences ERGO Interest Expense is $-0.08 Mil as of Dec. 2016.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Entia Biosciences's interest expense for the three months ended in Dec. 2016 was $ -0.04 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2016 was $-0.08 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Entia Biosciences's Operating Income for the three months ended in Dec. 2016 was $ -0.34 Mil. Entia Biosciences's Interest Expense for the three months ended in Dec. 2016 was $ -0.04 Mil. Entia Biosciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Entia Biosciences  (OTCPK:ERGO) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Entia Biosciences's Interest Expense for the three months ended in Dec. 2016 was $-0.04 Mil. Its Operating Income for the three months ended in Dec. 2016 was $-0.34 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2016 was $0.30 Mil.

Entia Biosciences's Interest Coverage for the quarter that ended in Dec. 2016 is calculated as

Entia Biosciences did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Entia Biosciences Interest Expense Historical Data

* Premium members only.

The historical data trend for Entia Biosciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entia Biosciences Interest Expense Chart

Entia Biosciences Annual Data
Trend Jul07 Jul08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.26 -0.15 -0.34 -0.17 -0.08

Entia Biosciences Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.01 -0.02 -0.02 -0.04

Entia Biosciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.08 Mil mean?
Entia Biosciences (ERGO) has a Interest Expense of $-0.08 Mil as of Dec. 2016. Interest Expense is the amount a company pays on its long-term debt. View historical data on Entia Biosciences and its competitors.
Is Entia Biosciences' Interest Expense too high?
Entia Biosciences' current Interest Expense is $-0.08 Mil.
How does Entia Biosciences' Interest Expense compare to OBMP and NSPX?
Entia Biosciences' Interest Expense of $-0.08 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Entia Biosciences and its competitors. Entia Biosciences's current Interest Expense is $-0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entia Biosciences stock overvalued right now?
Entia Biosciences (ERGO) has a current Interest Expense of $-0.08 Mil. The current Interest Expense is $-0.08 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Entia Biosciences (ERGO), the current Interest Expense is $-0.08 Mil as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entia Biosciences Business Description

Address 13565 South West Tualatin-Sherwood Road, Suite 800, Sherwood, OR, USA, 97140
Entia Biosciences Inc operates as a biotechnology company, is engaged in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products, principally in the United States of America. It market nutraceutical products under the name GROH and SANO directly to the consumers online. It currently offers natural organic nutraceutical mushroom dietary supplement products, ImmuSANO, GlucoSANO, and GROH, which has been designed to nutritionally support hair follicles and nail beds. It derives its revenue from the sale of its GROH line and mushroom-based nutraceutical dietary supplement products and functional ingredients.